/주식/VRNA
VRNA

VRNA

USD

Verona Pharma plc American Depositary Share

$106.910+0.060 (0.056%)

실시간 가격

Healthcare
생명공학
영국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$106.850

고가

$106.910

저가

$106.910

거래량

1.87M

기업 기본 정보

시가총액

9.1B

산업

생명공학

국가

United Kingdom

거래 통계

평균 거래량

1.69M

거래소

NGM

통화

USD

52주 범위

저가 $31.6현재가 $106.910고가 $106.93

관련 뉴스

Analyst Upgrades

Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target

Cantor Fitzgerald suspends Overweight rating on Verona Pharma PLC ADR and Maintains $100 price target

더 보기
Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target
BusinessWire

Merck Completes Acquisition of Verona Pharma

Acquisition strengthens Merck's cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade Merck (NYSE:MRK),

더 보기
Merck Completes Acquisition of Verona Pharma
GlobeNewswire

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on

더 보기
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
GlobeNewswire

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive

더 보기
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck